Insider screener

Period: 12 months Type of trade: Sold × Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

20,552 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

20,552 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

20,552 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

20,552 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
20,552 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
20,552 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

20,552 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
16 Jan 2026
Christopher Allen Mina Chief Tech Product Officer
Sold at will
$22.54K 7,152 at 3.15
12.0%
Not planned
16 Jan 2026
Leonard Reyno Chief Medical Officer
Sold at will
$22.20K 10,000 at 2.22
6.0%
Not planned
16 Jan 2026
John Andrew Paszterko Chief Operating Officer
Sold at will
$18.64K 18,457 at 1.01
3.1%
Not planned
16 Jan 2026
Eric Swayze EVP Research · indirect
Sold at will
$3.72K 49 at 75.97
13.4%
Not planned
16 Jan 2026
Shane Thomas Gleason Chief Commercial Officer
Sold at will
$3.63K 2,250 at 1.61
0.2%
Not planned
16 Jan 2026
Kieran O'Kane Chief Commercial Officer also filed by Gary Anthony Pestano
Sold at will
$2.43K 298 at 8.15
3.6%
Not planned
16 Jan 2026
Chris Vazquez Chief Accounting Officer
Sold at will
$676.39 83 at 8.15
7.2%
Not planned
15 Jan 2026
Douglas A Kehring EVP, Principal Financial Offcr
Sold on a plan
$6.82M 35,000 at 194.89
51.0%
Sold half or more
15 Jan 2026
Joel Reiss Co-Chief Operating Officer
Sold on a plan 18×
$5.58M 3,900 at 1,429.92
52.0%
Sold half or more
15 Jan 2026
Jason Phipps SVP Global Sales and Marketing
Sold on a plan
$5.30M 21,383 at 247.89
18.9%
Planned (10b5-1)
15 Jan 2026
Michelle Zatlyn President and Board Co-Chair · indirect
Sold on a plan 2×
$4.87M 25,641 at 190.05
51.1%
Sold half or more
15 Jan 2026
Chi Fung Cheng Chief Technology Officer · indirect
Sold on a plan 15×
$4.66M 30,000 at 155.47
0.5%
Planned (10b5-1)
15 Jan 2026
Paul A Mahon EVP & General Counsel
Sold on a plan 6×
$3.90M 8,300 at 469.89
18.4%
Planned (10b5-1)
15 Jan 2026
Timothy Price Crain II SVP and Chief Growth Officer
Sold on a plan
$3.41M 170,185 at 20.06
36.3%
Planned (10b5-1)
15 Jan 2026
Shane William Charles Kovacs Ch. Operating & Financial Off.
Sold at will
$2.87M 100,000 at 28.73
41.7%
Not planned
15 Jan 2026
Alain Bellemare EVP & Pres. - International
Sold at will
$2.49M 36,000 at 69.21
27.3%
Not planned
15 Jan 2026
John R. Furner Executive Vice President
Sold on a plan
$1.57M 13,125 at 119.99
1.8%
Planned (10b5-1)
15 Jan 2026
Nick Lane See Remarks
Sold on a plan 3×
$1.43M 30,000 at 47.65
23.1%
Planned (10b5-1)
15 Jan 2026
Dino DiPerna SVP Global R&D
Sold on a plan 2×
$1.24M 5,054 at 246.23
9.6%
Planned (10b5-1)
15 Jan 2026
Peter W Carter Chief External Affairs Officer
Sold at will
$1.01M 14,300 at 70.30
7.5%
Not planned
15 Jan 2026
Phillip D Carrai President, STC Division
Sold on a plan 7×
$801.42K 6,500 at 123.30
2.9%
Planned (10b5-1)
15 Jan 2026
Mark T Mondello Executive Chairman
Sold at will
$714.47K 2,800 at 255.17
0.2%
Not planned
15 Jan 2026
Sold on a plan 2×
$674.45K 30,000 at 22.48
2.8%
Planned (10b5-1)
15 Jan 2026
Margaret Hayne Co-President & CCO · indirect
Sold on a plan
$653.98K 9,333 at 70.07
0.4%
Planned (10b5-1)
15 Jan 2026
Christine Bellon Chief Legal Officer
Sold on a plan 3×
$644.83K 18,629 at 34.61
16.1%
Planned (10b5-1)
15 Jan 2026
Patrick Arthur Kelly Co-President and COO
Sold on a plan
$631.69K 35,568 at 17.76
2.3%
Planned (10b5-1)
15 Jan 2026
W. Todd Woelfer SVP, Chief Operating Officer
Sold at will
$524.50K 4,567 at 114.85
4.2%
Not planned
15 Jan 2026
Paul C Joseph EVP - Global Sales
Sold on a plan
$450.87K 5,000 at 90.17
22.2%
Planned (10b5-1)
15 Jan 2026
Sold at will 2×
$389.41K 1,925 at 202.29
1.9%
Not planned
15 Jan 2026
Johanna Mercier Chief Commercial Officer
Sold on a plan
$372.93K 3,000 at 124.31
2.8%
Planned (10b5-1)
15 Jan 2026
Bill Pereira COO & President
Sold at will
$372.88K 7,287 at 51.17
17.1%
Not planned
15 Jan 2026
Brian Daniel Webster See Remarks
Sold on a plan
$342.02K 15,000 at 22.80
3.7%
Planned (10b5-1)
15 Jan 2026
Michael David Garrison EVP & Pres Med.Essntl&BioPharm
Sold on a plan 2×
$334.01K 1,610 at 207.46
11.7%
Planned (10b5-1)
15 Jan 2026
Arvind Nithrakashyap Chief Technology Officer
Sold on a plan
$327.22K 4,648 at 70.40
1.4%
Planned (10b5-1)
15 Jan 2026
Jeffrey J Hurd Chief Operating Officer
Sold on a plan
$323.56K 6,790 at 47.65
11.0%
Planned (10b5-1)
15 Jan 2026
Brian Cree President
Sold on a plan
$320.90K 16,190 at 19.82
3.1%
Planned (10b5-1)
15 Jan 2026
Landon Edmond Chief Legal Officer
Sold on a plan 2×
$258.34K 10,000 at 25.83
2.8%
Planned (10b5-1)
15 Jan 2026
David Bredt Chief Scientific Officer
Sold on a plan 2×
$228.13K 8,500 at 26.84
2.1%
Planned (10b5-1)
15 Jan 2026
Joana Goncalves Chief Medical Officer
Sold on a plan 2×
$222.70K 7,000 at 31.81
82.2%
Sold half or more
15 Jan 2026
Chad M. Smith Pres & COO, Better Mortgage · indirect
Sold on a plan 2×
$220.22K 6,000 at 36.70
21.7%
Planned (10b5-1)
15 Jan 2026
Michael John Short President, Global Forwarding
Sold on a plan
$215.25K 1,230 at 175.00
2.2%
Planned (10b5-1)
15 Jan 2026
Marie Mendoza SVP & General Counsel
Sold on a plan
$201.42K 1,676 at 120.18
2.6%
Planned (10b5-1)
15 Jan 2026
Brendan Mulligan General Counsel and Secretary
Sold on a plan
$181.40K 5,666 at 32.02
0.7%
Planned (10b5-1)
15 Jan 2026
Daniel J Bartlett Executive Vice President
Sold on a plan
$166.56K 1,388 at 120.00
0.2%
Planned (10b5-1)
15 Jan 2026
Keith Cramer Chief Revenue Officer
Sold on a plan
$113.74K 10,000 at 11.37
5.3%
Planned (10b5-1)
15 Jan 2026
Mark Munch Exec VP&Pres Bruker Nano Inc.
Sold at will
$98.40K 2,000 at 49.20
1.5%
Not planned
15 Jan 2026
Sheela Kosaraju SVP and General Counsel
Sold on a plan
$94.06K 382 at 246.23
0.4%
Planned (10b5-1)
15 Jan 2026
Brian Kneafsey Head of Revenue
Sold on a plan
$76.42K 25,000 at 3.06
3.7%
Planned (10b5-1)
15 Jan 2026
Benjamin Louis Kirchhoff Chief Accounting Officer
Sold on a plan
$58.11K 1,683 at 34.53
1.7%
Planned (10b5-1)
Showing 16,851–16,900 of 20,552. ← Newer Page 338 of 412 Older →